EP3

General Information


DRACP ID  DRACP02038

Peptide Name   EP3

Sequence  AMVGT

Sequence Length  5

UniProt ID  Not available

PubChem CID  Not available

Origin  Eisenia fetida

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MGC-803 Gastric mucinous adenocarcinoma Carcinoma Observed by scanning electronic microscopy MTT assay 24 h, 48 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Short peptides with 5–7 amino acid residuals formed multimers in the PB buffer, which was a more likely explanation for the mechanism of EP3.

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02038

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C19H35N5O7S

Absent amino acids  CDEFHIKLNPQRSWY

Common amino acids  AGMTV

Mass  54911

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  2

Net charge  0

Boman Index  657

Hydrophobicity  136

Aliphatic Index  78

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  A novel antimicrobial vermipeptide family from earthworm Eisenia fetida

Doi 10.1016/j.ejsobi.2007.08.048

Year  2007

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_4319

DRACP is developed by Dr.Zheng's team.